IB-101

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameIB-101
Drug Alias NameIB-101
ClassificationBiologics
Mechanisms of ActionImmunostimulantsProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers +[4] 
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWestlake University
China Registration ClassN/A

Develop Information

Active CompaniesWestlake University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A